The COVID-19 pandemic is not expected to fully "end" in the near future but rather transition into an endemic phase, where the virus continues to circulate at more predictable, manageable levels like other common viral diseases. Experts predict that 2025 will largely resemble 2024 in terms of COVID-19 risk, with ongoing circulation of the virus, emergence of new variants likely related to Omicron, and the need for continued vaccination—especially for vulnerable populations. The virus will likely remain present but better controlled, similar to the flu, and there is no clear-cut end date for the pandemic given its potential to mutate and cause outbreaks.
Current Expert Views for 2025
- COVID-19 will continue to pose a constant but manageable threat in 2025.
- Vaccines remain critical to prevent severe illness and deaths.
- New variants will probably keep emerging but are expected to cause less severe disease due to immunity from vaccines and past infections.
- Ongoing surveillance, improved vaccines (possibly intranasal or universal), and therapeutics are key to managing COVID-19 long-term.
- Public health challenges include vaccine hesitancy and political/policy obstacles.
Pandemic vs Endemic Phase
- The pandemic phase is characterized by widespread, uncontrolled transmission and strains on healthcare systems.
- The endemic phase means steady, predictable circulation without overwhelming health resources.
- COVID-19 is moving toward endemicity but will still require vigilance and public health measures to keep it under control.
Summary
COVID-19 is unlikely to end abruptly but is expected to persist as an endemic virus, with 2025 resembling 2024 in terms of virus circulation and public health risks. Continued vaccination, monitoring for variants, and improved treatments will help manage it as a long-term health challenge rather than an acute pandemic.
